UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design

Trials, 2022-03, Vol.23 (1), p.193-193, Article 193

2022

Volltextzugriff (PDF)

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk

Journal of clinical oncology, 2020-08, Vol.38 (24), p.2762-2772

2020

Volltextzugriff (PDF)

Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy

Journal of clinical oncology, 2022-09, Vol.40 (27), p.JCO2100277-3204

2022

Volltextzugriff (PDF)

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

Journal of clinical oncology, 2022-07, Vol.40 (19), p.JCO2101958-2162

2022

Volltextzugriff (PDF)

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer

BMC cancer, 2010-05, Vol.10 (1), p.222-222, Article 222

2010

Volltextzugriff (PDF)

Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France

Breast (Edinburgh), 2016-12, Vol.30, p.73-79

2016

Volltextzugriff (PDF)

Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomas

Journal of clinical oncology, 2010-10, Vol.28 (28), p.e541-e542

2010

Volltextzugriff (PDF)

Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy

Anti-cancer drugs, 2011-11, Vol.22 (10), p.1020-1023

2011

Volltextzugriff (PDF)

Les traitements médicaux néoadjuvants des cancers du sein luminaux en 2016

Bulletin du cancer, 2017-01, Vol.104 (1), p.69-78

Cottu, Paul H.

2017

Volltextzugriff (PDF)

Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1064-1064

2021

Volltextzugriff (PDF)

Feasibility of treatment with another CDK4/6 inhibitor after severe ribociclib liver toxicity

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13067-e13067

2023

Volltextzugriff (PDF)

Influence of hormone therapy timing intake on disease free survival (DFS) for patients with high-risk early breast cancer: Results of the UCBG-UNIRAD phase III randomized trial

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.546-546

2023

Volltextzugriff (PDF)

Prediction of treatment (tx)-induced fatigue in breast cancer (BC) patients (pts) using machine learning on genome-wide association (GWAS) data in the prospective CANTO cohort

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.11515-11515

2019

Volltextzugriff (PDF)

Métastases cérébrales dans les cancers du sein. Épidémiologie et histoire naturelle. Expérience de l’Institut Curie à travers deux études : les patientes HER2- de moins de 65 ans et les patientes de plus de 65 ans

Bulletin du cancer, 2011-04, Vol.98 (4), p.357-369

2011

Volltextzugriff (PDF)

Métastases cérébrales dans les cancers du sein. Épidémiologie et histoire naturelle. Expérience de l'Institut Curie à travers deux études: les patientes HER2- de moins de 65 ans et les patientes de plus de 65 ans: Sein et maladie cérébro-méningée

Bulletin du cancer, 2011, Vol.98 (4), p.357-369

2011

Volltextzugriff (PDF)

Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study

The journal of pain, 2014-03, Vol.15 (3), p.293-303

2014

Volltextzugriff (PDF)

Prognosis of t1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas

Journal of clinical oncology, 2015-01, Vol.33 (3), p.291-291

2015

Volltextzugriff (PDF)

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma

PloS one, 2012-07, Vol.7 (7)

2012

Volltextzugriff (PDF)

ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?

Journal of geriatric oncology, 2014-10, Vol.5, p.S28-S28

2014

Volltextzugriff (PDF)

A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question

Journal of geriatric oncology, 2012-10, Vol.3, p.S34-S35

2012

Volltextzugriff (PDF)

Gastric metastases from breast cancer: A retrospective series of 12 patients

American journal of clinical oncology, 2001-08, Vol.24 (4), p.363-365

2001

Volltextzugriff (PDF)

Germ-cell tumours containing non germ-cell neoplasms: teratoma with malignant transformation

Urologic oncology, 2001, Vol.6 (6), p.239-242

2001

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(22)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(13)
Oncology
(12)
Female
(11)
Humans
(11)
Breast Cancer
(10)
Aged
(7)
Breast Neoplasms - Drug Therapy
(7)
Life Sciences
(7)
Middle Aged
(7)
Adult
(6)
Breast Neoplasms - Pathology
(5)
Chemotherapy
(5)
Patients
(4)
Tumors
(4)
Aged, 80 And Over
(3)
Cancer
(3)
Cancer Therapies
(3)
Clinical Trials
(3)
Hematology, Oncology And Palliative Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers

A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design

Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study

Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk

Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy

Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer

Assessment of the efficacy of successive endocrine therapies in hormone receptor–positive and HER2-negative metastatic breast cancer: a real-life multicentre national study

Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France

Trastuzumab treatment in t1ab, node-negative, human epidermal growth factor receptor 2-overexpressing breast carcinomas

Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy

Les traitements médicaux néoadjuvants des cancers du sein luminaux en 2016

Alpelisib and fulvestrant efficacy in HR-positive HER2-negative PIK3CA -mutant advanced breast cancer: Data from the French early access program

Feasibility of treatment with another CDK4/6 inhibitor after severe ribociclib liver toxicity

Influence of hormone therapy timing intake on disease free survival (DFS) for patients with high-risk early breast cancer: Results of the UCBG-UNIRAD phase III randomized trial

Prediction of treatment (tx)-induced fatigue in breast cancer (BC) patients (pts) using machine learning on genome-wide association (GWAS) data in the prospective CANTO cohort

Métastases cérébrales dans les cancers du sein. Épidémiologie et histoire naturelle. Expérience de l’Institut Curie à travers deux études : les patientes HER2- de moins de 65 ans et les patientes de plus de 65 ans

Métastases cérébrales dans les cancers du sein. Épidémiologie et histoire naturelle. Expérience de l'Institut Curie à travers deux études: les patientes HER2- de moins de 65 ans et les patientes de plus de 65 ans: Sein et maladie cérébro-méningée

Classification of and Risk Factors for Estrogen Deprivation Pain Syndromes Related to Aromatase Inhibitor Treatments in Women With Breast Cancer: A Prospective Multicenter Cohort Study

Prognosis of t1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma

ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?

A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question

Gastric metastases from breast cancer: A retrospective series of 12 patients

Germ-cell tumours containing non germ-cell neoplasms: teratoma with malignant transformation

Aktive Filter

Suchergebnisse filtern